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Abstract
Background: Sexual function is impaired in women with inflammatory bowel disease (IBD) as
compared to normal controls. We examined disease specific determinants of different aspects of
low sexual function.
Methods: Women with IBD aged 18 to 65 presenting to the university departments of internal
medicine and surgery were included. In addition, a random sample from the national patients
organization was used (separate analyses). Sexual function was assessed by the Brief Index of Sexual
Function in Women, comprising seven different domains of sexuality. Function was considered
impaired if subscores were < -1 on a z-normalized scale. Results are presented as age adjusted odds
ratios with 95% CI based on multiple logistic regression.
Results: 336 questionnaires were included (219 Crohn's disease, 117 ulcerative colitis). Most
women reported low sexual activity (63%; 17% none at all, 20% moderate or high activity).
Partnership satisfaction was high in spite of low sexual interest in this group. Depressed mood was
the strongest predictor of low sexual function scores in all domains. Urban residency and higher
socioecomic status had a protective effect. Disease activity was moderately associated with low
desire (OR 1.8, 95% CI 1.0 to 3.2). Severity of the disease course impacted most on intercourse
frequency (OR 2.3, 95% CI 1.4 to 4.7). Lubrication problems were more common in smokers (OR
2.5, 95% CI 1.3 to 5.1).
Conclusion: Mood disturbances and social environment impacted more on sexual function in
women with IBD than disease specific factors. Smoking is associated with lubrication problems.
Background
Ulcerative colitis and Crohn's disease typically affect ado-
lescents or young adults and are characterized by a chron-
ically remitting course. Many symptoms, complications
and consequences of these diseases are likely to impact on
body image, intimacy and sexual function [1]. Fatigue,
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further be aggravated by the embarrassing features of
incontinence and bad odours. Perianal disease affects
about one third of patients with Crohn's disease. Many
will require surgery, possibly including the installation of
a permanent or, more often, transient ostomy. Malnutri-
tion or medical therapy with corticosteroids may also be
associated with changes in the bodily appearance. Fur-
thermore, mood disorders, in particular depression, are
reported to be common in IBD [2]. Mood disorders are, at
the same time, known to constitute a major risk factor for
decreased sexual function [3].
It was therefore not surprising, when, almost 15 years ago,
Moody and Mayberry described significantly decreased
sexual activity in women with Crohn's disease, based on
structured interviews in 50 women with friend controls
[4]. Twenty-four percent of the cases abstained from sex-
ual activities altogether due to the disease (controls: 4%).
Moody and Mayberry complemented this study by
another survey including 50 women with ulcerative colitis
[5]. Since then, there has been very little research on this
issue as recently reviewed [6,7]. The few studies available
mostly focused on postoperative outcomes, as abdominal
surgery has the potential for structural changes or pelvic
nerve damage [8-10]. Many other issues concerning sexual
health in women with IBD remain unclear.
We have recently conducted a case control survey in mem-
bers of the German IBD patients organization [11]. These
persons form a relatively healthy group of IBD patients.
Even so, all aspects of female sexuality covered by a sensi-
tive validated instrument [12] were impaired in the IBD
cases, as compared to controls. In contrast to the results in
men, impaired function in women did not depend on the
activity of the disease but was also manifest in remission.
Due to the case-control design and the use of ambulatory
patients only, this previous survey offered little informa-
tion on disease specific risk factors.
To shed more light on the disease related determinants of
sexual function in women with IBD, we have now con-
ducted a survey in a well described clinical sample of
patients. Here, we present data from both surveys.
Methods
Participants
Consecutive patients with IBD, aged 18 to 65, were
included on presentation to the university hospital
departments of internal medicine and surgery. Patients
with major acute or chronic co-morbidity, unrelated to
IBD, were excluded if interference with quality of life and
sexuality in particular was considered likely. This was left
to the discretion of the treating physician. The list of
examples for exclusion included the following: chronic –
advanced cancer, complicated diabetes, neurological dis-
ease compromising mobility (such as stroke or multiple
sclerosis), remitting cardiac failure; acute – recent surgery
for any condition other than IBD, all patients currently in
or recently transferred from intensive care. Outpatients
were also recruited. The response rate was calculated as
the proportion of contacted persons returning a com-
pleted questionnaire.
This clinical group was complemented by cases from the
national patient organization (German Crohn's and Coli-
tis Association/Deutsche Crohn und Colitis Vereinigung,
DCCV e.V.). These had been selected randomly from the
members' list stratified by type of disease [11].
Questionnaire
Questionnaires were identical for the two groups (clinical
group and national patient organization) with respect to
the assessment of exposures and sexual function. For clin-
ical patients additional modules on disease specific qual-
ity of life were included (Short Inflammatory Bowel
Disease Questionnaire (S-IBDQ) [13], QLQ CR 38 mod-
ule of the European Organization for Research and Treat-
ment of Cancer (EORTC) [14].
Information on sociodemographic data, life style factors,
co-morbidity, and co-medication was collected using a
questionnaire module developed by the German IBD
Competence Network for use in IBD patients. Life style
factors included sports, smoking and alcohol consump-
tion. Socioeconomic status (SES) was calculated as a com-
posite measure based on income, education and
professional status, as suggested by the German Epidemi-
ological Association, DGEpi [15], and were summarized
as low, middle, and high.
Specific questions related to the presence of diabetes and
hypertension. Other co-morbidities and co-medications
were evaluated based on open questions. Diseases (such
as cardiovascular, hepatobiliary) and medications (such
as antihypertensive, antidepressant, other psychiatric)
were coded, grouped and used for a summary co-morbid-
ity measure: minor: one disease OR one medication;
major: a) at least one disease AND at least one medication
or b) more than one disease or medication.
The disease activity was classified as remission/low activ-
ity vs. moderate/high activity. The cut points were set at </
> 220 for Crohn's disease on a modified Crohn's Disease
Activity Index for use in surveys (S-CDAI), and </> 5 for
ulcerative colitis on the Clinical Activity Index survey ver-
sion (S-CAI). This instrument was previously validated
[16]. Disease course (severity) was graded as mild (less
than one relapse per year), medium (1 or 2 relapses per
year) and severe (frequent relapses or persistent prob-Page 2 of 10
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Hospital Anxiety and Depression Scale (HADS) [17,18].
Persons were considered depressed or anxious if the
respective HADS-Subscore exceeded 10.
Assessment of sexual function
As there was no validated questionnaire on female sexual
dysfunction available for the use in German language, the
Brief Index of Sexual Function in Women (BISF-W) was
transformed for use in German [12,19]. Formal cultural
adaptation methods were used as described for other
quality of life instruments [20]. This included independ-
ent translation of the questionnaire by two native speak-
ers of German and back-translation into English by a
native speaker of English. Further minor modifications of
the layout and wording were applied following a pilot
study in 60 persons (patients with and without IBD,
healthy volunteers) to improve understandibility and ease
of use. The questionnaire then underwent formal valida-
tion assessments, including test-retest reliability, internal
concistency, construct validity and sensitivity for change
[21]. Overall, the BISF-W showed excellent test properties
for all domains but the subscore of specific sexual problems,
which lacked internal consistency. This domain combines
several, mainly somatic problems occuring with sexual
intercourse in women, such as vaginismus, bleeding or
headaches after intercourse.
For subscores and the total score, higher values denote
better function with the exception of the specific sexual
problems (higher score = more problems). The scores were
calculated and transformed as suggested in the key-publi-
cation by Mazer [12]. Due to a layout problem in the
questionnaire, one of two items pertaining to the arousal
domain was incorrectly or not at all answered by the
majority of patients. Arousal scores will therefore be omit-
ted from the subscore presentation in this paper due to
limited interpretability. Tests on correctly completed
questionnaires showed that total scores were reliably esti-
mated without the missing item (correlation coefficient: r
= 0.99).
Results from a healthy German control group were used as
a standard population (friend controls from our matched
case control study). Due to a negative correlation with age
(in particular, for the subscores of intercourse frequency
and thoughts and desires), standardization was stratified
by age. Z-transformation results in a score where 0 repre-
sents the standard population mean, and 1 the standard
deviation. Low sexual function in any of the domains was
defined as a score < -1, representing a score lower than one
standard deviation from the mean score of the normative
sample.
The EORTC module for colorectal cancer patients was
chosen as it contains several direct questions on body
image, sexual function and satisfaction and ostomy func-
tion [14]. It generally applies four answer categories,
which were collapsed into two and presented as the pro-
portion of those answering definitely or rather positive
(vs. definitely or rather negative) for simplified graphical
display. Although previously used in IBD patients [22],
the instrument has not been developed and validated for
this purpose. Therefore, summary scores will not be pre-
sented.
Statistical analyses
For exploratory analyses graphical displays (means with
95% confidence intervals (95% CI)) are used. In addition,
the frequency of low scores is reported separately for both
study groups for descriptive purposes. As crude rates are
not comparable between women with and without part-
ners these figures are presented for women with partners
only. However, all women were included in the main
analyses.
Multivariate logistic regression was applied to calculate
adjusted odds ratios (OR) with 95% CI (SPSS©) [23].
Increased ratios (OR > 1.0) denote an increased risk for
low function in participants positive for the respective risk
factor. In the multivariate analyses, full models were ini-
tially calculated, including all potential risk factors, fol-
lowed by manual stepwise elimination based on model
fit, and the robustness and the statistical significance of
the estimated coefficients. All models were adjusted for
age and having a partner.
Ethical considerations
The study was approved by the ethics committee of the
institution (02/163). The steering board of the patients'
organization also approved of the protocol, question-
naires and information material. Clinical patients pro-
vided written consent. Patient organization members




Clinical patient recruitment took place from September 1,
2003 through October 31, 2005. 119 eligible women were
approached, 107 agreed to participate (90%). Of these, 95
returned a completed questionnaire (clinical sample
response rate 81%). No patient related characteristics
were found to be associated with response in this sample.
In addition, nineteen questionnaires from the outpatient
department were received. For this group, a response rate
could not be calculated as recruitment had to be pausedPage 3 of 10
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als (unknown denominator).
Of the patient organization member survey, 222 ques-
tionnaires were available for analysis (500 women
selected; response rate 44%). In this sample, the response
rate was higher in younger women (< 30 years of age:
58%). The combined sample comprised 336 women. 219
of these (65%) had Crohn's disease, 117 ulcerative colitis.
The sociodemographic and other characteristics by dis-
ease type and patient group are shown in Table 1. Patients
in the clinical group were younger. The regional East-
Bavarian catchment area of the university hospital is
reflected by high proportions of rural residency and
catholicism. Clinical patients were also more often
depressed and more often smokers. As expected, smoking
status was dependent on the type of disease (less smokers
in ulcerative colitis).
The comparison of the disease specific characteristics
revealed the expected higher proportion of patients with
severe or active disease and those on steroids in the clini-
cal group (Table 2). Long term immunosuppression, on
the other hand, was more common in the DCCV group,
which was also characterized by a longer disease duration
and higher percentage of past resecting surgery.
Sexual function – explorative analyses
In Figure 1, mean z-values for BISF-W subscores and the
total score are shown by study group with 95% CI,
restricted to women with partners for better comparabil-
ity. Case scores were consistently lower (or higher for spe-
cific problems) than 0 (representing the standard
population mean), but all deviations were minor (within
one standard deviation). For most subscores, patient
organization members scored slightly better than clinical
cases with the notable exception of partnership satisfac-
tion. Differences between the groups were not statistically
significant for any of the subscores.
On direct questioning (EORTC-items), issues relating to
feeling attractive or feminine as well as satisfaction with
the bodily appearance showed an association with disease
activity (p < 0.05 for all comparisons) (Figure 2, informa-
tion available for clinical sample only). There was a strik-
ingly low general interest in sexual activities in both
patients with active and quiescent disease. Only 20%
reported a high or moderate level of sexual activity during
the preceding four weeks. The proportion not sexually
active at all was 17%.
Determinants of impaired sexual function
Adjusted odds ratios from multivariate analyses are pre-
sented in Table 3 for selected variables. There was no evi-
dence for differences between patients with Crohn's
disease and patients with ulcerative colitis. Depressive
Table 1: Participants' characteristics – demographics and other general information
Group A – clinical Group B – DCCV
Crohn's disease Ulcerative colitis Crohn's disease Ulcerative colitis
Age (median) 38.5 yrs 38.0 yrs 38.0 yrs 38.0 yrs
Working fulltime 32 (36%) 5 (21%) 40 (31%) 31 (33%)
In training/at school 5 (6%) 1 (4%) 10 (8%) 5 (5%)
SES high 8 (10%) 4 (20%) 48 (39%) 35 (40%)
SES low 31 (38%) 5 (25%) 13 (11%) 3 (3%)
Urban residency 13 (15%) 5 (21%) 51 (40%) 36 (39%)
Smokers 46 (52%) 6 (25%) 38 (30%) 6 (7%)
Roman catholic 74 (82%) 15 (63%) 35 (27%) 27 (29%)
Protestant/Lutheran 9 (10%) 5 (21%) 55 (43%) 33 (36%)
Comorbidity, minor 19 (21%) 4 (3%) 20 (16%) 14 (15%)
Comorbidity, major 22 (24%) 5 (21%) 31 (24%) 24 (26%)
Diabetes 5 (6%) 6 (3%) 1 (1%) 2 (2%)
Antihypertensive Therapy 7 (8%) 4 (17%) 7 (5%) 5 (5%)
On hormonal contraception 25 (28%) 6 (25%) 29 (22%) 24 (26%)
On hormone replacement 3 (3%) 1 (4%) 5 (4%) 4 (3%)
Anxiety 33 (37%) 7 (30%) 38 (30%) 20 (22%)
Depression 19 (21%) 8 (35%) 12 (10%) 9 (10%)
Has a partner 61 (69%) 18 (78%) 93 (74%) 74 (80%)
Married 41 (46%) 16 (67%) 65 (51%) 53 (57%)
N 90 24 129 93
Not all categories shown for most variables.Page 4 of 10
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ciations for all subscores. Anxiety seemed to be of impor-
tance for the domain of intercourse frequency only. For
other characteristics, associations were sparse.
The multivariate analysis confirmed the difference in part-
nership satisfaction between clinical and DCCV cases:
women in the clinical group were less often dissatisfied,
even after adjustment for SES, disease activity, depression,
age and partnership status (OR 0.6; 95% CI 0.3 to 1.0).
Otherwise, there was no evidence for systematic differ-
ences between the two groups. Also, there was not differ-
ence between women with Crohn's disease and women
with ulcerative colitis.
Disease activity contributed to the prediction of a low
thoughts & desire score (OR 1.8; 95% CI 1.0 to 3.2). The
disease course (severity) was more consistently predictive
with OR > 1.0 for all subscores and a strong positive asso-
ciation with intercourse frequency (OR 2.3). Current use of
steroids was associated with low pleasure & orgasm scores.
For the presence of an ostomy or current perianal disease,
associations were not detected for any of the subscores.
The direction of the results for these factors was inconsist-
ent, rendering a relevant effect unlikely. Confidence inter-
vals for effects of these infrequent situations were too
wide to provide conclusive evidence.
In contrast, a marked differential effect was found for high
SES, which was protective of low thoughts & desire, but a
risk factor for low partnership satisfaction. Urban residency
showed consistently low odds ratios with strong negative
associations for initiative & receptivity and pleasure &
orgasm. Specific lifestyle factors (smoking, sports, alcohol)
did not show conclusive associations with any of the sub-
scores.
Specific sexual problems
As the subscore of specific sexual problems performed
poorly as an aggregate measure in the validation assess-
ment (see methods), analyses for this domain were based
on answers to single items. Insufficient lubrication was
reported to occur at least occasionally in 30% of the par-
ticipants who had a sexual relationship. Current smoking
was identified as a strong (and only) predictor of this
problem (OR 2.5, 95% CI 1.3 to 5.1). Pain during inter-
course was also quite common (25%), followed in preva-
lence by vaginal infections (9%) and vaginismusus (8%).
Predictors for any of these complaints were not identified.
In particular there was no difference by disease type or
activity, use of steroids, co-morbidity or presence of peri-
anal disease. Incontinence of urine during intercourse (n
= 5, 2%), headaches following sexual activity (n = 5; 2%)
and postcoital bleeding (n = 12; 5%) were considered too
Table 2: Participants' characteristics – disease related information (self reported)
Group A – clinical Group B – DCCV
Crohn's disease Ulcerative colitis Crohn's disease Ulcerative colitis
Disease duration (median) 9.0 yrs 6.0 yrs 13.0 yrs 9.0 yrs
Disease onset > 40 yrs 14 (16%) 3 (13%) 7 (6%) 6 (7%)
Disease onset < 18 yrs 16 (18%) 3 (13%) 28 (22%) 15 (17%)
Active disease 38 (42%) 19 (80%) 28 (22%) 31 (35%)
Mild disease course 22 (26%) 5 (23%) 44 (36%) 32 (37%)
Severe disease course 35 (42%) 7 (32%) 45 (37%) 21 (24%)
Past resecting surgery 38 (42%) 1 (4%) 73 (57%) 10 (11%)
Ostomy 10 (11%) 1 (4%) 13 (10%) 4 (5%)
Ileocecal resection 27 (30%) 48 (37%)
Perianal disease, current 19 (22%) 26 (21%)
Perianal disease, ever 23 (27%) 36 (28%)
Currently on steroids 39 (44%) 11 (48%) 35 (28%) 25 (28%)
Other immunosuppression 18 (20%) 6 (25%) 43 (34%) 19 (21%)
Total/substantial Colitis 14 (64%) 44 (49%)
Left sided colitis 5 (23%) 29 (33%)
Proctitis only 3 (14%) 16 (18%)
Small bowel only 14 (19%) 25 (20%)
Large bowel only 14 (19%) 37 (29%)
Combined disease 41 (56%) 61 (48%)
Upper Gi Involvement 4 (5%) 5 (4%)
N 90 24 129 93
Not all categories shown for most variables, missing values not reportedPage 5 of 10
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variate analysis.
The extent to which the disease was perceived to have had
a negative influence on sexual activities over the last four
weeks is displayed relative to other common distractors in
Figure 3.
Discussion
This study was designed to examine disease specific deter-
minants of impaired sexual function in women. The com-
bination of two different case groups enabled us to
examine both patients in their normal living environment
as well as those patients typically encountered by the uni-
versity specialist, representing a wide array of clinical
problems.
No particular feature of IBD was identified that would
explain the predescribed high prevalence of sexual imped-
iments in women suffering from this chronic disease.
Rather, the significance of psychosocial factors for female
sexuality, well known from studies in normal popula-
tions, was further underlined [24,25]. Foremost,
depressed mood was confirmed as the strongest and most
consistent risk factor. With the exception of specific sexual
problems, depression impacted on all aspects of sexuality
as assessed by the BISF-W. Anxiety seemed less important
but may play a role in certain aspects of sexuality (inter-
course frequency). Urban residency was protective for sev-
eral problems while the impact of socioeconomic status
varied by subscore: Women with a higher socioeconomic
status had higher scores for pleasure & orgasm, but scored
worse on partnership satisfaction.
This subscore was also unique in that it was the only score 
that differed between the two study groups
The clinical patients were characterized by a higher than
average level of partnership satisfaction. This phenomenon
was underlined by several free-text comments such as "the
disease has brought us closer together". Several women
expressed gratefulness for their understanding partners
who did not let them down in the difficult times of the
disease. The importance of an understanding social envi-
ronment, including the partner, for coping with IBD has
been repeatedly observed in studies using analytic inter-
views, foremost in the context of adjustment to an ostomy
[26].
It is unclear why this effect was different in the two groups
in spite of control for potential confounders of relation-
ship appreciation. As the DCCV sample suffered from a
rather low response rate, responder bias may have caused
this observation. Possibly, for some reason, women in
unsatisfactory relationships were more likely to respond.
BISF-W scores (z-values) by case group, women with partners onlyFigure 1
BISF-W scores (z-values) by case group, women with partners only. 0: standard population mean, +/- 1 = +/- 1 stand-
ard deviation from standard population mean. *specific problems: higher value = more problems, other scores: higher value = 
better function.Page 6 of 10
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tion in stressful situations is regionally different due to
cultural factors beyond those assessed (rural residency,
confession of faith, SES), or is different in persons joining
self help organizations.
The most striking finding in our survey might be the very
low levels of sexual interest and activity. A high prevalence
of low sexual desire is known from surveys in healthy
populations [24,27]. Although low desire is acknowl-
edged as a disease entity in the Diagnostic and Statistical
Table 3: Determinants of low sexual function




Pleasure & orgasm Partnership 
Satisfaction
BISF-W – Total 
Score
Clinical vs. DCCV 
case
1.4 (0.8 to 2.4) 1.3 (0.6 to 2.8) 1.3 (0.7 to 2.2) 1.5 (0.9 to 2.6) 0.6 (0.3 to 1.0) 0.9 (0.5 to 1.5)
Ulcerative colitis 
vs. Crohn's disease
1.3 (0.7 to 2.1) 1.4 (0.8 to 2.7) 1.3 (0.8 to 2.3) 1.3 (0.8 to 2.2) 1.1 (0.7 to 1.9) 1.3 (0.8 to 2.2)
Ostomy 0.8 (0.3 to 2.1) 1.2 (0.5 to 3.0) 1.5 (0.6 to 3.7) 0.5 (0.2 to 1.3) 0.9 (0.4 to 2.0) 0.7 (0.3 to 1.8)
Current perianal 
disease
0.8 (0.4 to 1.7) 1.6 (0.8 to 3.1) 0.7 (0.3 to 1.6) 0.8 (0.4 to 1.7) 1.7 (0.8 to 3.5) 1.0 (0.5 to 2.0)
Active disease 1.8 (1.0 to 3.2) 1.7 (0.9 to 3.1) 1.5 (0.8 to 2.7) 1.2 (0.7 to 2.1) 0.9 (0.5 to 1.6) 0.9 (0.5 to 1.6)
Frequent relapses 1.2 (0.6 to 2.3) 2.3 (1.4 to 4.7) 1.6 (0.8 to 3.1) 1.8 (0.9 to 3.5) 1.2 (0.7 to 2.3) 1.3 (0.7 to 2.4)
Disease duration > 
10 yrs
0.7 (0.3 to 1.7) 0.6 (0.3 to 1.5) 0.9 (0.4 to 2.1) 0.6 (0.3 to 1.2) 1.2 (0.5 to 2.6) 0.8 (0.4 to 1.7)
Current steroids 1.0 (0.6 to 1.7) 1.9 (1.1 to 3.3) 1.2 (0.7 to 2.0) 2.5 (1.5 to 4.4) 1.2 (0.7 to 1.9) 1.0 (0.6 to 1.7)
Urban residency 0.8 (0.4 to 1.5) 0.8 (0.4 to 1.4) 0.4 (0.2 to 0.8) 0.5 (0.3 to 0.9) 0.9 (0.5 to 1.6) 0.6 (0.3 to 1.0)
High SES 0.4 (0.2 to 0.8) 0.6 (0.2 to 1.3) 0.8 (0.3 to 2.0) 1.5 (0.8 to 2.8) 2.4 (1.0 to 5.5) 0.8 (0.3 to 1.7)
Co-morbidity 
(major)
1.4 (0.7 to 2.6) 1.9 (1.0 to 3.5) 1.1 (0.5 to 2.0) 1.5 (0.8 to 2.8) 1.8 (1.0 to 3.2) 1.3 (0.7 to 2.4)
Depression 2.9 (1.5 to 5.7) 3.5 (1.6 to 7.9) 4.4 (2.1 to 9.1) 4.8 (2.2 to 10.1) 2.7 (1.4 to 5.4) 3.4 (1.4 to 6.9)
Anxiety 1.6 (0.9 to 2.7) 2.0 (1.1 to 3.6) 1.4 (0.8 to 3.9) 1.7 (1.0 to 3.0) 1.5 (0.8 to 2.6) 1.4 (0.8 to 2.3)
All odds ratios (95% CI) controlled for age, partnership status and determinants significantly contributing to the respective model; n = 336 or less. 
Strong associations in bold font (OR > 2.0; OR < 0.5)
Results from EORTC-QLQ CR30 items, clinical sample only (n = 114)Fig re 2
Results from EORTC-QLQ CR30 items, clinical sample only (n = 114). Proportions of those answering "very"/"mod-
erate" (vs. "little"/"not at all").Page 7 of 10
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troversial whether it constitutes a sexual disorder [28,29].
For example, in women with chronic disease, loss of
desire might be considered a physiological response to
pain, fatigue or psychological distress. We do not wish to
imply that all women with low scores consider themselves
deficient or should receive treatment.
It was unfortunate that we were not able to calculate
arousal subscores for the majority of participants, as some
might suspect arousal to be particularly sensitive to struc-
tural changes or inflammatory processes in the perivagi-
nal and pelvic region. The BISF-W arousal domain focuses
on the subjective perception of sexual arousal which has
been shown to poorly correlate with the physiological
responses characterized by genital vasocongestion and
lubrication [30]. We were able to assess predictors of
lubrication as a somatic aspect of arousal and found a
strong association with smoking. Confounding by this
known risk factor of Crohn's disease should therefore be
considered when vaginal dryness in Crohn's disease is
reported. We are not aware of any data explaining this
effect of smoking on the vaginal mucosa and would wel-
come any discussion on this issue. There were no disease
specific determinants. In particular, there was no epidemi-
ological evidence for a causative effect of immunosup-
pression, disease activity, or perianal disease in the
pathogenesis of this or any of the other more common
specific sexual problems.
Our findings in women were quite different from our pre-
vious observations in men [31]. Erectile function was
mainly effected by somatic problems, while mood had
more impact on issues of satisfaction. A similarly clear cut
differentiation between the somatic and psychosocial
aspects of sexuality was not possible in women. This may
be innate to the more complex sequence of sexual behav-
ior in women [28]. In addition, our results confirm previ-
ously reported observations that women perceive the
impact of the disease on sexuality and partnership differ-
ently [32].
Conclusion
In summary, while low sexual function is common in
women with IBD, no specific disease related characteris-
tics were identified. Rather, as in women without chronic
disease, psychosocial factors play a predominant role.
While our data provide some basis for patient counsel-
ling, the existence and relevance of sexual problems and
any need for therapy should be determined individually
in sympathetic patient-doctor interviews, if the patient
wishes to do so. Often, treatment of mood disorders
might be more important than specific sexual therapy.
With respect to the most common specific sexual prob-
lem, insufficient lubrication, our study provides yet
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